Allianz Asset Management’s CureVac CVAC Stock Holding History

Allianz Asset Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,100	Closed	-$209K	–	2446
2021 Q4	$209K	Hold	6,100	–	–	﹤0.01%	2479
2021 Q3	$333K	Buy	+6,100	New	+$368K	﹤0.01%	2378

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Allianz Asset Management's CVAC Position: Q1 2022 in Review

Allianz Asset Management sold out of CureVac (CVAC) in Q1 2022, closing a stake of 6,100 shares — an estimated $209K sold.

Allianz Asset Management first reported a position in CVAC in Q3 2021 and held it in 2 quarters. The position peaked at $333K in Q3 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q1 2022.

Allianz Asset Management reported no remaining CureVac position as of Q1 2022 after selling out during the quarter.
Allianz Asset Management sold 6,100 CureVac shares in Q1 2022, an estimated $209K.
Allianz Asset Management first reported a position in CureVac in Q3 2021 and held it in 2 quarters.
Allianz Asset Management's CureVac position peaked at $333K in Q3 2021.
111 funds tracked by Wall St. Rank held CureVac as of Q1 2022.

Based on Allianz Asset Management's 13F filing for Q1 2022, filed 13 May 2022.